Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Account Payables: 2018-2019

Historic Change in Account Payables for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$130,000.

  • DiaMedica Therapeutics' Change in Account Payables fell 155.56% to -$130,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$301,000, marking a year-over-year decrease of 903.33%. This contributed to the annual value of $14,000 for FY2024, which is 92.71% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its Change in Account Payables stood at -$130,000 for Q4 2019, which was down 360.00% from $50,000 recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Change in Account Payables registered a high of $234,000 during Q4 2018, and its lowest value of -$422,000 during Q2 2019.
  • Over the past 2 years, DiaMedica Therapeutics' median Change in Account Payables value was -$30,500 (recorded in 2018), while the average stood at -$41,375.
  • Data for DiaMedica Therapeutics' Change in Account Payables shows a peak YoY increase of 770.00% (in 2019) and a maximum YoY decrease of 1,261.29% (in 2019) over the last 5 years.
  • DiaMedica Therapeutics' Change in Account Payables (Quarterly) stood at $234,000 in 2018, then crashed by 155.56% to -$130,000 in 2019.
  • Its last three reported values are -$130,000 in Q4 2019, $50,000 for Q3 2019, and -$422,000 during Q2 2019.